Bommi founded MaxVal in 2004 to help companies optimize the management of patent lifecycles and maximize the value of their patents. His initial efforts in monetizing patents in the life sciences arena led to a sophisticated approach at MaxVal for processing patent portfolios in various sectors for monetization. Bommi has assembled a talented leadership team that operates globally to develop high quality, cost-effective solutions for patent groups.
Bommi’s patent experience started as an inventor while a graduate student, then becoming a patent agent at his job as a research scientist, followed by various stints at the Bay Area’s many prestigious law firms such as Morrison Foerster, Cooley Godward, and Thelen Reid & Priest, and in-house at companies like Alza. Bommi’s exposure to patent practice at law firms and in-house has given him a unique perspective that has laid the foundation for many of the solutions offered by MaxVal. Before founding MaxVal, Bommi was the CEO at NTERO Surgical, Inc., a medical device company that he co-founded with support from Menlo Ventures, where he learned to handle the challenges of raising capital, assembling a top notch team and developing products.
Bommi’s work experience includes research and management positions at Merck, Cygnus, and Alza. He is an inventor on more than 20 patents and has published more than 50 articles in scientific journals. He is a registered patent attorney (USPTO and California).
J.D. Stanford Law School (Order of the Coif)
Ph.D. Bioengineering. Joint program between UC San Francisco and UC Berkeley
M.S. Chemical Engineering, Indian Institute of Technology, Kanpur
B.Tech. Chemical Engineering. Anna University